A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered

- Jackson, Evangeline R., Persson, Mika L., Fish, Cameron J., Findlay, Izac J., Mueller, Sabine, Nazarian, Javad, Hulleman, Esther, van der Lugt, Jasper, Duchatel, Ryan J., Dun, Matthew D.

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models

- de la Nava, Daniel, Ausejo-Mauleon, Iker, Tallon-Cobos, Antonio Carlos, Hernandez-Osuna, Reyes, Marco-Sanz, Javier, Dhandapani, Laasya, Hervás-Corpión, Irati, Becher, Oren J., Nazarian, Javad, Mueller, Sabine, Phoenix, Timothy N., van der Lugt, Jasper, Laspidea, Virginia, Hernaez, Mikel, Guruceaga, E, Koschmann, C, Venneti, S, Allen, JE, Dun, Matthew D., Fueyo, J, Gomez-Manzano, C, Perez-Larraya, JG, Patiño-García, A, Gonzalez-Huarriz, Marisol, Labiano, S, Alonso, MM, Lacalle, Andrea, Casares, Noelia, Zalacain, Marta, Marrodan, Lucía, García-Moure, Marc, Ochoa, Maria C.

Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology

- Foster, Jessica B., Alonso, Marta M., Sayour, Elias, Davidson, Tom B., Persson, Mika L., Dun, Matthew D., Kline, Cassie, Mueller, Sabine, Vitanza, Nicholas A., van der Lugt, Jasper